Condition

Nasopharyngeal Squamous Cell Carcinoma (3)

Concurrent Chemoradiotherapy (1)

Induction Chemotheray (1)

Locally Recurrent Head and Neck Squamous Cell Carcinoma (1)

Reduce Treatment Intensity (1)

Sinonasal Squamous Cell Carcinoma (1)

Stage II, III (1)

Toxicity Due to Radiotherapy (1)

Overall Status

Recruiting (2)

Completed (1)

Phase

phase 1 (1)

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Air Force Military Medical University, China (1)

Chinese Academy of Medical Sciences (1)

National Cancer Institute (NCI) (1)

Collaborator

Intervention

birinapant (1)

cisplatin (1)

docetaxel (1)

docetaxel and cisplatin (1)

gemcitabine and cisplatin (1)

imrt (1)

intensity-modulated radiation therapy (1)

Study Documents

Intervention Type

drug (3)

radiation (2)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

nasopharyngeal squamous cell carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Locally Recurrent Head and Neck Squamous Cell Carcinoma, Nasopharyngeal Squamous Cell Carcinoma, Sinonasal Squamous Cell

Recruiting

Locally Recurrent Head and Neck Squamous Cell Carcinoma
+2 more

Birinapant
Intensity-Modulated Radiation Therapy

Birmingham, Alabama
+32 more

Aug 20, 2022

Stage II, III, Nasopharyngeal Squamous Cell Carcinoma, Induction Chemotheray Trial in Beijin (Docetaxel, Cisplatin, IMRT)

Recruiting

Stage II, III
+4 more

Docetaxel
+2 more

Beijin, China

Chinese Academy of Medical Sciences

Jan 28, 2021

Nasopharyngeal Squamous Cell Carcinoma, Toxicity Due to Radiotherapy Trial in Xi'an (gemcitabine and cisplatin, docetaxel and

Completed

Nasopharyngeal Squamous Cell Carcinoma
Toxicity Due to Radiotherapy

gemcitabine and cisplatin
docetaxel and cisplatin

Xi'an, Shanxi, China

Department of Radiation Oncology, Xijing Hospital, Fourth Milita

Oct 29, 2013